Table 3.
Parameters | Training cohort (n = 43) | Validation cohort (n = 43) | Total cohort (n = 86) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
High risk | Low risk | χ2 | P | High risk | Low risk | χ2 | P | High risk | Low risk | χ2 | P | |
Age (y) | 0.352 | 0.553 | 0.011 | 0.916 | 0.047 | 0.829 | ||||||
<14 | 13 | 12 | 7 | 7 | 19 | 20 | ||||||
>14 | 11 | 7 | 14 | 15 | 24 | 23 | ||||||
Gender | 0.266 | 0.206 | 0.011 | 0.916 | 0.047 | 0.828 | ||||||
Male | 12 | 8 | 14 | 14 | 24 | 25 | ||||||
Female | 12 | 11 | 7 | 8 | 19 | 18 | ||||||
Race | 0.687 | 1.000 | 0.386 | 1.000 | ||||||||
White | 15 | 16 | 8 | 12 | 22 | 29 | 0.618 | 0.904 | ||||
Asian | 1 | 1 | 2 | 3 | 3 | 4 | ||||||
Black | 2 | 1 | 2 | 2 | 4 | 3 | ||||||
Metastasis | 1.063 | 0.302 | 3.376 | 0.066 | 5.103 | 0.024 | ||||||
Positive | 7 | 3 | 8 | 3 | 15 | 6 | ||||||
Negative | 17 | 16 | 13 | 19 | 28 | 37 | ||||||
Progression | 1.21 | 0.271 | 0.099 | 0.753 | 1.269 | 0.26 | ||||||
Positive | 7 | 1 | 3 | 4 | 10 | 5 | ||||||
Negative | 3 | 2 | 9 | 9 | 11 | 12 |
The bold value means statistically significant.